Nacua, Francisco .
HRN: 12-93-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/14/2025
10/21/2025
IV
4.5g
Q8
VENOUS STASIS DERMATITIS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes